A novel nomogram for predicting 3-year mortality in critically ill patients after coronary artery bypass grafting

HuanRui Zhang1, Wen Tian1, YuJiao Sun2

  • 1Department of Geriatric Cardiology, The First Affiliated Hospital of China Medical University, NO.155 Nanjing North Street, Heping Ward, Shenyang, 110001, China.

BMC Surgery
|December 1, 2021
PubMed

Insights

A new nomogram accurately predicts 3-year mortality in critically ill patients after coronary artery bypass grafting (CABG). This tool aids in improving long-term outcomes and patient management post-surgery.

Area of Science:

  • Cardiovascular Surgery
  • Critical Care Medicine
  • Medical Informatics

Background:

  • Long-term outcomes after coronary artery bypass grafting (CABG) are a growing concern.
  • Existing models primarily focus on in-hospital mortality, with limited research on long-term prediction.
  • There is a need for reliable tools to predict mortality beyond the immediate postoperative period.

Purpose of the Study:

  • To develop and validate a novel nomogram for predicting 3-year mortality in critically ill patients following CABG.
  • To create a tool that offers improved prognostic accuracy compared to existing methods.

Main Methods:

  • Utilized data from the Medical Information Mart for Intensive Care III (MIMIC-III) database.
  • Enrolled 2929 critically ill patients who underwent CABG during their first admission.
  • Employed multivariable logistic regression to identify independent prognostic factors.

Main Results:

  • A nomogram was constructed using seven independent prognostic factors: age, congestive heart failure, white blood cell count, creatinine, SpO2, anion gap, and continuous renal replacement treatment.
  • The nomogram demonstrated accurate discrimination in both primary (AUC: 0.81) and validation cohorts (AUC: 0.802).
  • Calibration curves and decision curve analysis confirmed its superior performance and clinical utility over traditional severity scores.

Conclusions:

  • The developed nomogram exhibits strong performance in predicting 3-year mortality for critically ill patients post-CABG.
  • This predictive model offers valuable insights for treatment strategies and post-discharge management.
  • The tool has the potential to enhance long-term prognosis for this patient population.
Abstract

Related Concept Videos

Dosage Regimen Designs: Nomograms and Tabulations01:23

Dosage Regimen Designs: Nomograms and Tabulations

Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
21
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
41
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
22